STOCK TITAN

Nasdaq warns Society Pass (SOPA) after 30 days below $1 bid minimum

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Society Pass Incorporated has received a notice from Nasdaq that its common stock has closed below the required $1.00 minimum bid price for the last thirty consecutive business days, putting it out of compliance with Nasdaq Listing Rule 5550(a)(2).

The company has 180 calendar days, until September 22, 2026, to regain compliance by having its stock close at or above $1.00 for at least ten consecutive business days. The notice does not immediately affect the stock’s listing, but failure to recover by the deadline could lead to delisting, subject to possible extension and appeal.

Positive

  • None.

Negative

  • Nasdaq bid-price deficiency and delisting risk: SOPA’s shares have traded below Nasdaq’s $1.00 minimum for thirty consecutive business days, starting a 180‑day cure period to regain compliance, with the possibility of further review, corporate actions, and potential delisting if the issue is not resolved.

Insights

Nasdaq bid-price deficiency creates clear delisting risk window for SOPA.

Society Pass has fallen below Nasdaq’s $1.00 minimum bid for thirty straight business days, triggering a formal deficiency notice. The company now operates under a defined 180‑day cure period ending September 22, 2026, during which its stock must close at or above $1.00 for ten consecutive sessions.

The notice alone does not change trading status, but it signals elevated listing risk. If the price does not recover, the company may seek a second 180‑day period, which requires meeting other initial listing standards and formally outlining a cure plan, such as a reverse stock split.

If Nasdaq staff concludes the deficiency cannot be cured or eligibility criteria are not met, the shares could be delisted, though the company would have the right to appeal. Future disclosures will clarify whether the board pursues corporate actions like a reverse split and whether Nasdaq grants any additional grace period.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
false 0001817511 0001817511 2026-03-26 2026-03-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 26, 2026

 

SOCIETY PASS INCORPORATED

(Exact name of registrant as specified in its charter)

 

Nevada   001-41037   83-1019155

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

 

701 S. Carson Street, Suite 200 Carson City, Nevada 89701

(Address of principal executive offices)

 

(+65) 6518-9385

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act.

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   SOPA   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


 
 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On March 26, 2026, Society Pass Incorporated (the “Company”) received a letter (the “Nasdaq Staff Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until September 22, 2026 to regain compliance. The letter states that the Nasdaq staff will provide written notification that the Company has achieved compliance with Rule 5550(a)(2) if at any time before September 22, 2026, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of ten (10) consecutive business days. The Nasdaq Staff Letter has no immediate effect on the listing or trading of the Company’s common stock.

 

The Company intends to monitor the bid price of its common stock and consider available options if its common stock does not trade at a level likely to result in the Company regaining compliance with Nasdaq’s minimum bid price rule by September 22, 2026.

 

If the Company does not regain compliance with Rule 5550(a)(2) by September 22, 2026, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period, for example, by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq would notify the Company that its securities would be subject to delisting. In the event of such a notification, the Company may appeal the Nasdaq staff’s determination to delist its securities. There can be no assurance that the Company will be eligible for the additional 180 calendar day compliance period, if applicable, or that the Nasdaq staff would grant the Company’s request for continued listing subsequent to any delisting notification.

 

Forward-Looking Statements

 

This current report contains “forward-looking statements” within the meaning of the U.S. federal securities laws. Forward-looking statements can be identified by words such as “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar references to future periods. Examples of forward-looking statements in this current report include, without limitation, statements regarding the Company’s intent to monitor the bid price of its common stock and consider available options, including a reverse stock split; and the Company’s eligibility for an additional 180 calendar day compliance period. Forward-looking statements are statements that are not historical facts, nor assurances of future performance. Instead, they are based on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties, and actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual results to differ include, without limitation, there can be no assurance that the Company will meet the bid price requirement during any compliance period or otherwise in the future, otherwise meet Nasdaq compliance standards, that Nasdaq will grant the Company any relief from delisting as necessary or whether the Company can agree to or ultimately meet applicable Nasdaq requirements for any such relief, and the other important factors described under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2025 and its other filings with the SEC. Any forward-looking statement made by the Company in this current report is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Society Pass Incorporated
   
  By: /s/ Raynauld Liang
  Name: Raynauld Liang
  Title: Chief Executive Officer
     
Date: March 27, 2026    

 

3

FAQ

What Nasdaq notice did Society Pass (SOPA) receive on March 26, 2026?

Society Pass received a Nasdaq Staff Letter stating its common stock failed to meet the $1.00 minimum bid price requirement for thirty consecutive business days, triggering a bid‑price deficiency under Nasdaq Listing Rule 5550(a)(2) and starting a defined compliance period to cure the shortfall.

How long does Society Pass (SOPA) have to regain Nasdaq bid-price compliance?

Society Pass has 180 calendar days, until September 22, 2026, to regain compliance. It must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days within this period to satisfy Nasdaq Listing Rule 5550(a)(2).

Does the Nasdaq deficiency letter immediately affect trading of SOPA stock?

The Nasdaq Staff Letter has no immediate effect on the listing or trading of Society Pass’s common stock. Shares remain listed on The Nasdaq Capital Market while the company works within the 180‑day compliance window to restore the required minimum bid price level.

What options might Society Pass (SOPA) consider to regain Nasdaq compliance?

Society Pass intends to monitor its bid price and consider available options. The filing notes that, if needed during a second compliance period, the company could cure the deficiency by actions such as effecting a reverse stock split to lift the per‑share trading price.

Can Society Pass (SOPA) obtain an additional 180-day Nasdaq compliance period?

If SOPA does not regain compliance by September 22, 2026, it may qualify for another 180‑day period. This would require meeting all other initial listing standards, including market value of publicly held shares, and providing written notice of its intention to cure the bid‑price deficiency.

What happens if Nasdaq moves to delist Society Pass (SOPA) shares?

If Nasdaq staff determines the deficiency will not be cured or eligibility is lacking, it may notify Society Pass that its securities are subject to delisting. The company would then have the right to appeal that determination, though the outcome of any appeal is not assured.

Filing Exhibits & Attachments

3 documents
Society Pass Incorporated

NASDAQ:SOPA

View SOPA Stock Overview

SOPA Rankings

SOPA Latest News

SOPA Latest SEC Filings

SOPA Stock Data

5.40M
12.52M
Advertising Agencies
Services-business Services, Nec
Link
Singapore
SINGAPORE